Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia

Circulation. 2004 May 4;109(17):2109-15. doi: 10.1161/01.CIR.0000125742.65841.8B. Epub 2004 Mar 29.

Abstract

Background: Hypercholesterolemia (HC) and atherosclerosis can elicit oxidative stress, coronary endothelial dysfunction, and myocardial ischemia, which may induce growth-factor expression and lead to myocardial neovascularization. We tested the hypothesis that chronic antioxidant intervention in HC would attenuate neovascularization and preserve the expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF).

Methods and results: Three groups of pigs (n=6 each) were studied after 12 weeks of normal or 2% HC diet or HC+antioxidant supplementation (100 IU/kg vitamin E and 1 g vitamin C daily). Myocardial samples were scanned ex vivo with a novel 3D micro-CT scanner, and the spatial density and tortuosity of myocardial microvessels were determined in situ. VEGF mRNA, protein levels of VEGF and VEGF receptor-1, HIF-1alpha, nitrotyrosine, and superoxide dismutase (SOD) were determined in myocardial tissue. The HC and HC+antioxidant groups had similar increases in serum cholesterol levels. HC animals showed an increase in subendocardial spatial density of microvessels compared with normal (160.5+/-11.8 versus 95.3+/-8.2 vessels/cm2, P<0.05), which was normalized in HC+antioxidant (92.5+/-20.5 vessels/cm2, P<0.05 versus HC), as was arteriolar tortuosity. In addition, HC induced upregulation of VEGF, HIF-1alpha, and nitrotyrosine expression and decreased SOD expression and activity, all of which were preserved by antioxidant intervention.

Conclusions: Changes in myocardial microvascular architecture invoked by HC are accompanied by increases in HIF-1alpha and VEGF expression and attenuated by antioxidant intervention. This underscores a role of increased oxidative stress in modulating myocardial microvascular architecture in early atherogenesis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Arteriosclerosis / etiology
  • Ascorbic Acid / administration & dosage
  • Ascorbic Acid / therapeutic use*
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / therapeutic use*
  • Coronary Circulation / drug effects*
  • Diet, Atherogenic
  • Dinoprost / blood
  • Enzyme Induction / drug effects
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Heart / diagnostic imaging
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy*
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Imaging, Three-Dimensional
  • Myocardial Ischemia / etiology
  • Myocardial Ischemia / physiopathology
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / prevention & control*
  • Oxidative Stress / drug effects
  • Superoxide Dismutase / biosynthesis
  • Superoxide Dismutase / genetics
  • Swine
  • Tomography, X-Ray Computed
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics
  • Tyrosine / analogs & derivatives*
  • Tyrosine / biosynthesis
  • Vascular Endothelial Growth Factor A / biosynthesis
  • Vascular Endothelial Growth Factor A / genetics
  • Vitamin E / administration & dosage
  • Vitamin E / therapeutic use*

Substances

  • Antioxidants
  • Cardiotonic Agents
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Vitamin E
  • 3-nitrotyrosine
  • Tyrosine
  • Dinoprost
  • Superoxide Dismutase
  • Ascorbic Acid